All Stories

  1. Atherosclerosis as a Localised Amyloid and Proteostasis Disorder
  2. Unlocking substrate specificities of human solute carrier proteins using untargeted metabolomics
  3. Post-translational modifications in the insoluble fraction of platelet-poor plasma distinguish pre-COVID-19 Postural Orthostatic Tachycardia Syndrome, Long COVID, and Long COVID-POTS: a preliminary study
  4. Bioinformatic assessment of the potential amyloidogenicity of the human and evolutionarily more ancient proteomes
  5. Advances, challenges, and opportunities in engineering C5 and C6 sugar transporters in yeast for bio-based industrial biotechnology
  6. Why Standard Tests Miss Spike-Induced Clot Alterations
  7. Uncovering the Hidden Biology of Fibrinaloid Microclot Complexes in Complex, Inflammatory Diseases
  8. Assessing the Health and Functionality of the Microcirculation Using Thermal Imaging
  9. On the Correspondence of Diseases Showing Microparticles, Fibrinaloid Microclots and Disorders of the Microcirculation
  10. An imaging flow cytometry method to study platelet-monocyte aggregates using Long COVID as a model
  11. How far can you go? Extrapolating values of catalytic activity from known protein landscapes in natural and directed evolution
  12. Rapid antimicrobial susceptibility testing in bloodstream infections: current landscape and emerging technologies
  13. Uncovering the hidden biology of fibrinaloid microclot complexes in complex, inflammatory diseases
  14. Post-translational modifications within fibrinaloid microclot complexes distinguish Pre-COVID-19 Postural Orthostatic Tachycardia Syndrome, Long COVID, and Long COVID-POTS and reveal disease-specific molecular pathways
  15. Rapid accumulation of fluorophores and fast kill identify drugs with bactericidal effects against Gram-negative bacteria
  16. Inflammatory Triggers, Cell Death, Membrane Damage and Lipid Asymmetry That Shape Procoagulant Surfaces for Amyloidogenic Microclotting
  17. Assessing the Health and Functionality of the Microcirculation Using Thermal Imaging
  18. AmyloGram Reveals Amyloidogenic Potential in Stroke Thrombus Proteomes
  19. The Effects of Pseudoserum on Thrombin-Induced Fibrin Networks: Potential for Clinical Insight into Coagulation Independent of Clotting Factors
  20. Potential Roles of Fibrinaloid Microclot Complexes in Inhibiting the Cochlear Microcirculation During the Development of Tinnitus
  21. Amyloidogenic Potential of Plaque and Thrombus Proteomes and of Fold-Switching Metamorphic Proteins
  22. A novel metacyte metafer classifier for platelet morphology using long COVID as a model
  23. AmyloGram Reveals Amyloidogenic Potential in Stroke Thrombus Proteomes
  24. Rapid accumulation of fluorophores and fast kill identify drugs with bactericidal effects against Gram-negative bacteria
  25. Membrane proteins ClcB, PtsI and YcaM mediate the bactericidal effects of colistin in Escherichia coli
  26. Assessment of the Impacts of Fibrinaloid Microclots on the Microcirculation and Endothelial Function, Using Laser Speckle and Laser Doppler Imaging
  27. On the Utility of Nailfold Capillaroscopy in Detecting the Effects of Fibrinaloid Microclots in Diseases Involving Blood Stasis
  28. Amyloid Presence in Acute Ischemic Stroke Thrombi: Observational Evidence for Fibrinolytic Resistance
  29. Exercise-induced Changes in Microclotting and Cytokine Levels Point to Vascular Injury and Inflammation in People with Long COVID
  30. Virus-Induced Endothelial Senescence as a Cause and Driving Factor for ME/CFS and Long COVID: Mediated by a Dysfunctional Immune System
  31. A Direct Relationship Between ‘Blood Stasis’ and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment
  32. The Roles of Placental Senescence, Autophagy and Senotherapeutics in the Development and Prevention of Pre-Eclampsia: A Focus on Ergothioneine
  33. A Direct Relationship Between ‘Blood Stasis’ and Fibrinaloid Microclots in Chronic, Inflammatory and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment
  34. A Direct Relationship Between ‘Blood Stasis’ and Fibrinaloid Microclots in Chronic, Inflammatory and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment
  35. The Proteome Content of Blood Clots Observed Under Different Conditions: Successful Role in Predicting Clot Amyloid(ogenicity)
  36. Treatment of Long COVID With Enoxaparin
  37. The proteome content of blood clots observed under different conditions: successful role in predicting clot amyloid(ogenicity)
  38. The clots removed from ischaemic stroke patients by mechanical thrombectomy are amyloid in nature
  39. Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots
  40. Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook
  41. The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects
  42. Proteomic evidence for amyloidogenic cross-seeding in fibrinaloid microclots
  43. Evidence for the Role of the Mitochondrial ABC Transporter MDL1 in the Uptake of Clozapine and Related Molecules into the Yeast Saccharomyces cerevisiae
  44. Flow Clotometry: Measuring Amyloid Microclots in ME/CFS, Long COVID, and Healthy Samples with Imaging Flow Cytometry
  45. Fibrinaloid Microclots and Atrial Fibrillation
  46. Herpesvirus Infection of Endothelial Cells as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  47. Automated microscopic measurement of fibrinaloid microclots and their degradation by nattokinase, the main natto protease
  48. Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al.
  49. Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID
  50. Fibrinaloid Microclots and Atrial Fibrillation
  51. Herpesvirus Infection as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  52. A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations
  53. Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
  54. Hyperparameter optimisation in differential evolution using Summed Local Difference Strings, a rugged but easily calculated landscape for combinatorial search problems
  55. Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia
  56. Data sharing: A Long COVID perspective, challenges, and road map for the future
  57. Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis
  58. Long COVID: pathophysiological factors and abnormalities of coagulation
  59. Treatment of Long COVID symptoms with triple anticoagulant therapy
  60. Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome
  61. Alzheimer’s Disease: A Systems View Provides a Unifying Explanation of Its Development
  62. Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia
  63. Understanding Functional Redundancy and Promiscuity of Multidrug Transporters in E. coli under Lipophilic Cation Stress
  64. Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis
  65. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
  66. The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
  67. Analysis of a Library of Escherichia coli Transporter Knockout Strains to Identify Transport Pathways of Antibiotics
  68. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
  69. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
  70. The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
  71. The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
  72. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC)
  73. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
  74. SpeedyGenesXL: an Automated, High-Throughput Platform for the Preparation of Bespoke Ultralarge Variant Libraries for Directed Evolution
  75. Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) can resolve their persistent symptoms
  76. Engineering ergothioneine production in Yarrowia lipolytica
  77. MassGenie: A Transformer-Based Deep Learning Method for Identifying Small Molecules from Their Mass Spectra
  78. TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
  79. MassGenie: A Transformer-Based Deep Learning Method for Identifying Small Molecules From Their Mass Spectra
  80. Intelligent host engineering for metabolic flux optimisation in biotechnology
  81. Membrane Transporters Involved in the Antimicrobial Activities of Pyrithione in Escherichia coli
  82. The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes
  83. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
  84. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
  85. A decision-tree approach to treat platelet hyperactivity and anomalous blood clotting in acute COVID-19 patients
  86. MassGenie: a transformer-based deep learning method for identifying small molecules from their mass spectra
  87. Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
  88. FragNet, a Contrastive Learning-Based Transformer Model for Clustering, Interpreting, Visualizing, and Navigating Chemical Space
  89. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19
  90. A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters
  91. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
  92. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
  93. Deep learning and generative methods in cheminformatics and chemical biology: navigating small molecule space intelligently
  94. Structural Similarities between Some Common Fluorophores Used in Biology, Marketed Drugs, Endogenous Metabolites, and Natural Products
  95. Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
  96. Bacteria, Lipopolysaccharides, Amyloid and the Role of Iron Dysregulation in Parkinson’s Disease
  97. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19
  98. DeepGraphMolGen, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach
  99. A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery
  100. DeepGraphMolGen, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach
  101. Prevalence of amyloid blood clots in COVID-19 plasma
  102. VAE-Sim: A Novel Molecular Similarity Measure Based on a Variational Autoencoder
  103. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
  104. COVID-19: The Rollercoaster of Fibrin(ogen), D-dimer, von Willebrand Factor, P-selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
  105. VAE-Sim: a novel molecular similarity measure based on a variational autoencoder
  106. A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for bacterial membrane transporters
  107. DeepGraphMol, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach
  108. An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
  109. The Atypical Fibrin Fibre Network in Rheumatoid Arthritis and its Relation to Autoimmunity, Inflammation and Thrombosis
  110. DeepGraphMol, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach
  111. Author Correction: Hitchhiking into the cell
  112. Hitchhiking into the cell
  113. The biology of ergothioneine, an antioxidant nutraceutical
  114. Why most transporter mutations that cause antibiotic resistance are to efflux pumps rather than to import transporters
  115. The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data
  116. Structural similarities between some common fluorophores used in biology and marketed drugs, endogenous metabolites, and natural products
  117. Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli
  118. A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
  119. GeneORator: An Effective Strategy for Navigating Protein Sequence Space More Efficiently through Boolean OR-Type DNA Libraries
  120. Parkinson’s disease: a systemic inflammatory disease accompanied by bacterial inflammagens
  121. Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli
  122. Very rapid flow cytometric assessment of antimicrobial susceptibility during the apparent lag phase of microbial (re)growth
  123. Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
  124. Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris
  125. Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer’s Type Dementia
  126. Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson’s Disease, Alzheimer’s Disease and Type 2 Diabetes Mellitus
  127. The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
  128. An automated Design-Build-Test-Learn pipeline for enhanced microbial production of fine chemicals
  129. Energetic evolution of cellular Transportomes
  130. No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases
  131. Belief Book
  132. Control of metabolite efflux in microbial cell factories: current advances and future prospects
  133. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease
  134. PartsGenie: an integrated tool for optimizing and sharing synthetic biology parts
  135. Selenzyme: enzyme selection tool for pathway design
  136. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains
  137. GeneGini: Assessment via the Gini Coefficient of Reference “Housekeeping” Genes and Diverse Human Transporter Expression Profiles
  138. Engineering the “Missing Link” in Biosynthetic (−)-Menthol Production: Bacterial Isopulegone Isomerase
  139. Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father†
  140. Fast and Flexible Synthesis of Combinatorial Libraries for Directed Evolution
  141. Ultra-high throughput functional enrichment of large monoamine oxidase (MAO-N) libraries by fluorescence activated cell sorting
  142. Analysing and Navigating Natural Products Space for Generating Small, Diverse, But Representative Chemical Libraries
  143. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
  144. Immunological tolerance, pregnancy and pre-eclampsia: the roles of semen microbes and the father
  145. PartsGenie: an integrated tool for optimising and sharing synthetic biology parts
  146. Selenzyme: Enzyme selection tool for pathway design
  147. A Metabolic Reaction Balancing Web Service for Computational Systems Biology
  148. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities
  149. Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation
  150. To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?
  151. biochem4j: Integrated and extensible biochemical knowledge through graph databases
  152. CodonGenie: optimised ambiguous codon design tools
  153. Mass spectrometry imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3×Tg Alzheimer mouse model
  154. Novel ‘housekeeping’ genes and an unusually heterogeneous distribution of transporter expression profiles in human tissues and cell lines, assessed using the Gini coefficient
  155. Consensus rank orderings of molecular fingerprints illustrate the most genuine similarities between marketed drugs and small endogenous human metabolites, but highlight exogenous natural products as the most important ‘natural’ drug transporter substrates
  156. Both Lipopolysaccharide And Lipoteichoic Acids Potently Induce Anomalous Fibrin Amyloid Formation: Assessment With Novel Amytracker™ Stains
  157. Lipopolysaccharide-Binding Protein (LBP) Can Reverse The Amyloid State Of Fibrin Seen Or Induced In Parkinson's Disease: Implications For Its Aetiology
  158. Evolutionary algorithms and synthetic biology for directed evolution: commentary on “on the mapping of genotype to phenotype in evolutionary algorithms” by Peter A. Whigham, Grant Dick, and James Maclaurin
  159. Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine
  160. Analysis of drug–endogenous human metabolite similarities in terms of their maximum common substructures
  161. Computing exponentially faster: implementing a non-deterministic universal Turing machine using DNA
  162. Consensus rank orderings of molecular fingerprints illustrate the most genuine similarities between marketed drugs and small endogenous human metabolites, but highlight exogenous natural products as the most important natural drug transporter substrate...
  163. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability
  164. Commentary on “Goodacre R, Timmins ÉM, Rooney PJ, Rowland JJ, Kell DB: Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform in...
  165. SYNBIOCHEM Synthetic Biology Research Centre, Manchester – A UK foundry for fine and speciality chemicals production
  166. A Dormant Microbial Component in the Development of Preeclampsia
  167. SpeedyGenes: Exploiting an Improved Gene Synthesis Method for the Efficient Production of Synthetic Protein Libraries for Directed Evolution
  168. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide
  169. The metabolome 18 years on: a concept comes of age
  170. MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites
  171. A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease
  172. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting
  173. SYNBIOCHEM-a SynBio foundry for the biosynthesis and sustainable production of fine and speciality chemicals
  174. Recon 2.2: from reconstruction to model of human metabolism
  175. Microbes and Alzheimer’s Disease
  176. Response to ‘The Need for Speed’, by Matsson et al.
  177. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness
  178. The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on their bulk biophysical properties: Towards a systems pharmacology
  179. The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities
  180. Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)
  181. Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly
  182. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death
  183. Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
  184. Software review: the KNIME workflow environment and its applications in genetic programming and machine learning
  185. Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
  186. Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
  187. The dormant blood microbiome in chronic, inflammatory diseases
  188. Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis
  189. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen)
  190. Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently
  191. What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?
  192. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics
  193. The virtue of innovation: innovation through the lenses of biological evolution
  194. Alignment by numbers: sequence assembly using compressed numerical representations
  195. Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182
  196. How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion
  197. Eryptosis as a marker of Parkinson's disease
  198. Erratum to: A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
  199. A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
  200. Evidence That Multiple Defects in Lipid Regulation Occur before Hyperglycemia during the Prodrome of Type-2 Diabetes
  201. SpeedyGenes: an improved gene synthesis method for the efficient production of error-corrected, synthetic protein libraries for directed evolution
  202. Molecular phenotyping of a UK population: defining the human serum metabolome
  203. Event-based text mining for biology and functional genomics
  204. GeneGenie: optimized oligomer design for directed evolution
  205. Controlled vocabularies and semantics in systems biology
  206. Resuscitation of “Uncultured” Microorganisms
  207. Mental health: Drug search on risky path
  208. Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery
  209. Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents
  210. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
  211. Yeast cells with impaired drug resistance accumulate glycerol and glucose
  212. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
  213. An analysis of a ‘community-driven’ reconstruction of the human metabolic network
  214. A model of yeast glycolysis based on a consistent kinetic characterisation of all its enzymes
  215. A method for integrating and ranking the evidence for biochemical pathways by mining reactions from text
  216. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
  217. A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy
  218. Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
  219. A community-driven global reconstruction of human metabolism
  220. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
  221. Kinetic Parameter Information Resource, KiPar
  222. High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease
  223. Path2Models: large-scale generation of computational models from biochemical pathway maps
  224. Exploiting Genomic Knowledge in Optimising Molecular Breeding Programmes: Algorithms from Evolutionary Computing
  225. Reviews turn facts into understanding
  226. Extracting semantically enriched events from biomedical literature
  227. Large-scale sequestration of atmospheric carbon via plant roots in natural and agricultural ecosystems: why and how
  228. A systematic survey of the response of a model NF-
  229. Genome-wide analysis of longevity in nutrient-deprived Saccharomyces cerevisiae reveals importance of recycling in maintaining cell viability
  230. Scientific discovery as a combinatorial optimisation problem: How best to navigate the landscape of possible experiments?
  231. Short- and long-term dynamic responses of the metabolic network and gene expression in yeast to a transient change in the nutrient environment
  232. The genetic control of growth rate: a systems biology study in yeast
  233. Improving metabolic flux predictions using absolute gene expression data
  234. Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets
  235. Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing
  236. Absolute Quantification of the Glycolytic Pathway in Yeast:: DEPLOYMENT OF A COMPLETE QconCAT APPROACH
  237. Concussion's impact
  238. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy
  239. Breeding crop plants with deep roots: their role in sustainable carbon, nutrient and water sequestration
  240. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
  241. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
  242. Metabolic Profiling Uncovers a Phenotypic Signature of Small for Gestational Age in Early Pregnancy
  243. Defrosting the Digital Library
  244. Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets
  245. Interactions among oscillatory pathways in NF-kappa B signaling
  246. Predicting the points of interaction of small molecules in the NF-κB pathway
  247. Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast
  248. Metabolites do social networking
  249. Systematic integration of experimental data and models in systems biology
  250. Mining metabolites: extracting the yeast metabolome from the literature
  251. Changes in the Metabolic Footprint of Placental Explant-Conditioned Medium Cultured in Different Oxygen Tensions from Placentas of Small for Gestational Age and Normal Pregnancies
  252. Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers
  253. Utopia documents: linking scholarly literature with research data
  254. Convergent evolution to an aptamer observed in small populations on DNA microarrays
  255. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
  256. Enzyme kinetics informatics: from instrument to browser
  257. Predictive models for population performance on real biological fitness landscapes
  258. Event extraction for systems biology by text mining the literature
  259. Arcadia: a visualization tool for metabolic pathways
  260. Further developments towards a genome-scale metabolic model of yeast
  261. Calling International Rescue: knowledge lost in literature and data landslide!
  262. Real-time vapour sensing using an OFET-based electronic nose and genetic programming
  263. Changes in the Metabolic Footprint of Placental Explant-Conditioned Culture Medium Identifies Metabolic Disturbances Related to Hypoxia and Pre-Eclampsia
  264. Erratum: The Systems Biology Graphical Notation
  265. Development and Performance of a Gas Chromatography−Time-of-Flight Mass Spectrometry Analysis for Large-Scale Nontargeted Metabolomic Studies of Human Serum
  266. Journal club
  267. The Systems Biology Graphical Notation
  268. Analysis of a complete DNA-protein affinity landscape
  269. Aptamer evolution for array-based diagnostics
  270. Serum Metabolite Biomarkers In Alzheimer's Disease
  271. Visualising biological data: a semantic approach to tool and database integration
  272. Pulsatile Stimulation Determines Timing and Specificity of NF- B-Dependent Transcription
  273. Low cost, portable, fast multiparameter data acquisition system for organic transistor odour sensors
  274. Systems approach
  275. Dormant microbes: time to revive some old ideas
  276. KiPar, a tool for systematic information retrieval regarding parameters for kinetic modelling of yeast metabolic pathways
  277. In silico modelling of directed evolution: Implications for experimental design and stepwise evolution
  278. Scientific Abstracts
  279. Development of a Robust and Repeatable UPLC−MS Method for the Long-Term Metabolomic Study of Human Serum
  280. Anaesthetic function
  281. Implications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material)
  282. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
  283. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics
  284. Optimal construction of a fast and accurate polarisable water potential based on multipole moments trained by machine learning
  285. Analysis of aptamer sequence activity relationships
  286. ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries
  287. Deterministic mathematical models of the cAMP pathway in Saccharomyces cerevisiae
  288. Information management for high content live cell imaging
  289. Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape
  290. Progress being made on standards for use in data sharing
  291. Sensitivity analysis and robust experimental design of a signal transduction pathway system
  292. Defrosting the Digital Library: Bibliographic Tools for the Next Generation Web
  293. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology
  294. Performing statistical analyses on quantitative data in Taverna workflows: An example using R and maxdBrowse to identify differentially-expressed genes from microarray data
  295. Metabolic profiling of serum using Ultra Performance Liquid Chromatography and the LTQ-Orbitrap mass spectrometry system
  296. Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox Biomarkers
  297. Detection and Identification of Novel Metabolomic Biomarkers in Preeclampsia
  298. The markup is the model: Reasoning about systems biology models in the Semantic Web era
  299. Facilitating the development of controlled vocabularies for metabolomics technologies with text mining
  300. Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo
  301. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
  302. Comparative evaluation of software for deconvolution of metabolomics data based on GC-TOF-MS
  303. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols
  304. Information-theoretic sensitivity analysis: a general method for credit assignment in complex networks
  305. Proximate parameter tuning for biochemical networks with uncertain kinetic parameters
  306. The landscape adaptive particle swarm optimizer
  307. Rapid prediction of optimum population size in genetic programming using a novel genotype -
  308. Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures
  309. Metabolite profiles of interacting mycelial fronts differ for pairings of the wood decay basidiomycete fungus, Stereum hirsutum with its competitors Coprinus micaceus and Coprinus disseminatus
  310. Automated manipulation of systems biology models using libSBML within Taverna workflows
  311. Something from nothing − bridging the gap between constraint-based and kinetic modelling
  312. Transcriptional and metabolic response of Saccharomyces cerevisiae to a nutritional perturbation when under stress
  313. Proposed minimum reporting standards for data analysis in metabolomics
  314. Metabolic footprinting as a tool for discriminating between brewing yeasts
  315. Metabolomic biomarkers: search, discovery and validation
  316. Improving Data Fitting of a Signal Transduction Model by Global Sensitivity Analysis
  317. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate
  318. Towards a mathematical model of the cAMP pathway in S. cerevisiae
  319. Multiobjective Optimization in Bioinformatics and Computational Biology
  320. The methodologies of systems biology
  321. The virtual human: Towards a global systems biology of multiscale, distributed biochemical network models
  322. Peptide detectability following ESI mass spectrometry
  323. Growth control of the eukaryote cell: a systems biology study in yeast
  324. Automated tracking of gene expression in individual cells and cell compartments
  325. Closed-Loop, Multiobjective Optimization of Two-Dimensional Gas Chromatography/Mass Spectrometry for Serum Metabolomics
  326. Systems biology, metabolic modelling and metabolomics in drug discovery and development
  327. Text mining and its potential applications in systems biology
  328. Statistical strategies for avoiding false discoveries in metabolomics and related experiments
  329. Metabolomics: The new science of metabolic integration
  330. Automatic tracking of biological cells and compartments using particle filters and active contours
  331. The Role of Modeling in Systems Biology
  332. Metabolomics, modelling and machine learning in systems biology - towards an understanding of the languages of cells. Delivered on 3 July 2005 at the 30th FEBS Congress and 9th IUBMB conference in Budapest
  333. Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
  334. Insights into the behaviour of systems biology models from dynamic sensitivity and identifiability analysis: a case study of an NF-κB signalling pathway
  335. Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation
  336. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops
  337. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning
  338. A laser desorption ionisation mass spectrometry approach for high throughput metabolomics
  339. Metabolic footprinting and systems biology: the medium is the message
  340. A general model of error-prone PCR
  341. Metabolomics, machine learning and modelling: towards an understanding of the language of cells
  342. Computational cluster validation in post-genomic data analysis
  343. A metabolome pipeline: from concept to data to knowledge
  344. Closed-Loop, Multiobjective Optimization of Analytical Instrumentation:  Gas Chromatography/Time-of-Flight Mass Spectrometry of the Metabolomes of Human Serum and of Yeast Fermentations
  345. Synergistic control of oscillations in the NF-B signalling pathway
  346. Vacuum packing: a model system for laboratory-scale silage fermentations
  347. A proposed framework for the description of plant metabolomics experiments and their results
  348. Differentiation of Micromonospora Isolates from a Coastal Sediment in Wales on the Basis of Fourier Transform Infrared Spectroscopy, 16S rRNA Sequence Analysis, and the Amplified Fragment Length Polymorphism Technique
  349. Oscillations in NF- B Signaling Control the Dynamics of Gene Expression
  350. Discrimination of Modes of Action of Antifungal Substances by Use of Metabolic Footprinting
  351. OBSERVED DYNAMICS OF LARGE SCALE PARALLEL EVOLUTIONARY ALGORITHMS WITH IMPLICATIONS FOR PROTEIN ENGINEERING
  352. Selective Detection of Proteins in Mixtures Using Electrospray Ionization Mass Spectrometry:  Influence of Instrumental Settings and Implications for Proteomics
  353. Estimation of Microbial Viability Using Flow Cytometry
  354. Metabolomics and systems biology: making sense of the soup
  355. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-κB pathway: the roles of IKK and IκBα
  356. Metabolomics by numbers: acquiring and understanding global metabolite data
  357. Metabolomics by numbers: acquiring and understanding global metabolite data
  358. Single-nucleotide polymorphism detection using nanomolar nucleotides and single-molecule fluorescence
  359. High-Throughput Metabolic Fingerprinting of Legume Silage Fermentations via Fourier Transform Infrared Spectroscopy and Chemometrics
  360. Functional genomic hypothesis generation and experimentation by a robot scientist
  361. Fast automatic registration of images using the phase of a complex wavelet transform: application to proteome gels
  362. Comparative Genomic Assessment of Novel Broad-Spectrum Targets for Antibacterial Drugs
  363. Explanatory Optimization of Protein Mass Spectrometry via Genetic Search
  364. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting
  365. A systematic approach to modeling, capturing, and disseminating proteomics experimental data
  366. Evolutionary Computation for the Interpretation of Metabolomic Data
  367. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era
  368. Adoption of the transiently non-culturable state — a bacterial survival strategy?
  369. Functional Genomics via Metabolic Footprinting: Monitoring Metabolite Secretion byEscherichia coliTryptophan Metabolism Mutants Using FT–IR and Direct Injection Electrospray Mass Spectrometry
  370. Primary and secondary metabolism, and post-translational protein modifications, as portrayed by proteomic analysis of Streptomyces coelicolor
  371. Genotype–phenotype mapping: genes as computer programs
  372. A family of autocrine growth factors in Mycobacterium tuberculosis
  373. The rpf gene of Micrococcus luteus encodes an essential secreted growth factor
  374. Metabolic profiling using direct infusion electrospray ionisation mass spectrometry for the characterisation of olive oils
  375. Schemes of flux control in a model of Saccharomyces cerevisiae glycolysis
  376. Monitoring of complex industrial bioprocesses for metabolite concentrations using modern spectroscopies and machine learning: Application to gibberellic acid production
  377. Rapid and Quantitative Detection of the Microbial Spoilage of Meat by Fourier Transform Infrared Spectroscopy and Machine Learning
  378. Monitoring of complex industrial bioprocesses for metabolite concentrations using modern spectroscopies and machine learning: Application to gibberellic acid production
  379. The Cytochrome P450 Complement (CYPome) of Streptomyces coelicolor A3(2)
  380. Flow-injection electrospray ionization mass spectrometry of crude cell extracts for high-throughput bacterial identification
  381. Differentiation of Phytophthora infestans Sporangia from Other Airborne Biological Particles by Flow Cytometry
  382. Comprehensive Natural Products Chemistry, Volume 4: Amino Acids, Peptides, Porphyrins and Alkaloids
  383. Sample preparation in matrix-assisted laser desorption/ionization mass spectrometry of whole bacterial cells and the detection of high mass (>20?kDa) proteins
  384. Histometrics: Improvement of the dynamic range of fluorescently stained proteins resolved in electrophoretic gels using hyperspectral imaging
  385. Histometrics: Improvement of the dynamic range of fluorescently stained proteins resolved in electrophoretic gels using hyperspectral imaging
  386. Discrimination of Aerobic Endospore-forming Bacteria via Electrospray-Ionization Mass Spectrometry of Whole Cell Suspensions
  387. Genomic Computing. Explanatory Analysis of Plant Expression Profiling Data Using Machine Learning
  388. Chemometric criteria for the characterisation of Italian Protected Denomination of Origin (DOP) olive oils from their metabolic profiles
  389. Chemometric criteria for the characterisation of Italian Protected Denomination of Origin (DOP) olive oils from their metabolic profiles
  390. MEG (Model Extender for Gepasi): a program for the modelling of complex, heterogeneous, cellular systems
  391. Macromolecular interactions: tracing the roots
  392. Culturability of Mycobacterium tuberculosis cells isolated from murine macrophages: a bacterial growth factor promotes recovery
  393. Culturability of Mycobacterium tuberculosis cells isolated from murine macrophages: a bacterial growth factor promotes recovery
  394. On-Line, Real-Time Measurements of Cellular Biomass using Dielectric Spectroscopy
  395. Bacterial dormancy and culturability: the role of autocrine growth factors Commentary
  396. Screen idols: faster, smaller, cheaper and smarter
  397. Efficient Improvement of Silage Additives by Using Genetic Algorithms
  398. On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: the need for machine learning
  399. Non-linear dielectric spectroscopy: antifouling and stabilisation of electrodes by a polymer coating
  400. Correction of the influence of baseline artefacts and electrode polarisation on dielectric spectra
  401. Snapshots of Systems
  402. The use of nonlinear dielectric spectroscopy to monitor the bioelectromagnetic effects of a weak pulsed magnetic field in real time
  403. The use of nonlinear dielectric spectroscopy to monitor the bioelectromagnetic effects of a weak pulsed magnetic field in real time
  404. Dormancy in Non-Sporulating Bacteria: Its Significance for Environmental Monitoring
  405. A Portable Flow Cytometer for the Detection and Identification of Microorganisms
  406. Intelligent Systems for the Characterization of Microorganisms from Hyperspectral Data
  407. Detection of the Dipicolinic Acid Biomarker in Bacillus Spores Using Curie-Point Pyrolysis Mass Spectrometry and Fourier Transform Infrared Spectroscopy
  408. Intelligent systems for the characterization and quantification of microbial systems from advanced analytical techniques
  409. Noninvasive, On-Line Monitoring of the Biotransformation by Yeast of Glucose to Ethanol Using Dispersive Raman Spectroscopy and Chemometrics
  410. Use of 13 C nuclear magnetic resonance distortionless enhancement by polarization transfer pulse sequence and multivariate analysis to discriminate olive oil cultivars
  411. Rapid analysis of the expression of heterologous proteins in Escherichia coli using pyrolysis mass spectrometry and Fourier transform infrared spectroscopy with chemometrics: application to α2-interferon production
  412. Characterisation of intact microorganisms using electrospray ionisation mass spectrometry
  413. Characterisation of intact microorganisms using electrospray ionisation mass spectrometry
  414. Stimulation of the multiplication of Micrococcus luteus by an autocrine growth factor
  415. Genetic programming as an analytical tool for non-linear dielectric spectroscopy
  416. Screensavers: trends in high-throughput analysis
  417. Revolutionary ideas come round again
  418. Variable selection and multivariate methods for the identification of microorganisms by flow cytometry
  419. A weak pulsed magnetic field affects adenine nucleotide oscillations, and related parameters in aggregating Dictyostelium discoideum amoebae
  420. Estimation of Microbial Viability Using Flow Cytometry
  421. From code to mode for orphan genes
  422. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation
  423. Variable Selection in Discriminant Partial Least-Squares Analysis
  424. Systematic functional analysis of the yeast genome
  425. The influence of electrode polarisation on dielectric spectra, with special reference to capacitive biomass measurements:
  426. The influence of electrode polarisation on dielectric spectra, with special reference to capacitive biomass measurements
  427. A bacterial cytokine
  428. Quantification of microbial productivity via multi-angle light scattering and supervised learning
  429. Variable selection in wavelet regression models
  430. The effect of heteroscedastic noise on the chemometric modelling of frequency domain data
  431. Rapid analysis of microbial systems using vibrational spectroscopy and supervised learning methods: application to the discrimination between methicillin-resistant and methicillin-susceptible Staphy
  432. Dielectric estimation of microbial biomass using the Aber Instruments Biomass Monitor
  433. The deconvolution of pyrolysis mass spectra using genetic programming: application to the identification of some Eubacterium species
  434. The deconvolution of pyrolysis mass spectra using genetic programming: application to the identification of some Eubacterium species
  435. A DRASTIC (Diffuse Reflectance Absorbance Spectroscopy Taking in Chemometrics) approach for the rapid analysis of microbial fermentation products: Quantification of aristeromycin and neplanocin A in Streptomyces citricolor broths
  436. DRASTIC(Diffuse Reflectance Absorbance Spectroscopy Taking In Chemometrics). A novel, rapid, hyperspectral, FT-IR-based approach to screening for biocatalytic activity and metabolite overproduction
  437. Discrimination between methicillin-resistant and methicillin- susceptible Staphylococcus aureus using pyrolysis mass spectrometry and artificial neural networks
  438. Rheological phenomena occurring during the shearing flow of mayonnaise
  439. Genetic Programming:  A Novel Method for the Quantitative Analysis of Pyrolysis Mass Spectral Data
  440. Target practice — novel approaches to antimicrobial chemotherapy
  441. Standardized basis sets for high-level-correlated relativistic calculations of atomic and molecular electric properties in the spin-averaged Douglas-Kroll approximation
  442. Fluorescent brighteners: Novel stains for the flow cytometric analysis of microorganisms
  443. Enantioselectivity of sulcatone reduction by some anaerobic bacteria
  444. Diffuse reflectance absorbance spectroscopy taking in chemometrics (DRASTIC). A hyperspectral FT-IR-based approach to rapid screening for metabolite overproduction
  445. Discrimination of the variety and region of origin of extra virgin olive oils using 13C NMR and multivariate calibration with variable reduction
  446. On mass spectrometer instrument standardization and interlaboratory calibration transfer using neural networks
  447. Genetic algorithms as a method for variable selection in multiple linear regression and partial least squares regression, with applications to pyrolysis mass spectrometry
  448. Classification of pyrolysis mass spectra by fuzzy multivariate rule induction-comparison with regression, K-nearest neighbour, neural and decision-tree methods
  449. An introduction to wavelet transforms for chemometricians: A time-frequency approach
  450. Quantitative analysis of the adulteration of orange juice with sucrose using pyrolysis mass spectrometry and chemometrics
  451. Determination of the geographical origin of Italian extra virgin olive oil using pyrolysis mass spectrometry and artificial neural networks
  452. If you've got it, flaunt it — rapid screening for microbial biocatalysts
  453. Improving the interpretation of multivariate and rule induction models by using a peak parameter representation
  454. Wavelet Denoising of Infrared Spectra
  455. Making cells work — metabolic engineering for everyone
  456. An instrument for the acquisition and analysis of the nonlinear dielectric spectra of biological samples
  457. What Biotechnologists Knew All Along...?
  458. Going places: forced and natural molecular evolution
  459. Plant seed classification using pyrolysis mass spectrometry with unsupervised learning: The application of auto-associative and Kohonen artificial neural networks
  460. Quantitative Analysis of Multivariate Data Using Artificial Neural Networks: A Tutorial Review and Applications to the Deconvolution of Pyrolysis Mass Spectra
  461. Rapid and non-invasive quantification of metabolic substrates in biological cell suspensions using non-linear dielectric spectroscopy with multivariate calibration and artificial neural networks. Principles and applications
  462. Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks
  463. Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks
  464. Do bacteria need to communicate with each other for growth?
  465. Membrane tension
  466. Why and when channelling can decrease pool size at constant net flux in a simple dynamic channel
  467. Deconvolution of the dielectric spectra of microbial cell suspensions using multivariate calibration and artificial neural networks
  468. Pyrolysis mass spectrometry and its applications in biotechnology
  469. Correction of Mass Spectral Drift Using Artificial Neural Networks
  470. On the analysis of the inverse problem of metabolic pathways using artificial neural networks
  471. Rapid authentication of animal cell lines using pyrolysis mass spectrometry and auto-associative artificial neural networks
  472. Oscillatory, stochastic and chaotic growth rate fluctuations in permittistatically controlled yeast cultures
  473. GMP — good modelling practice: an essential component of good manufacturing practice
  474. Preparation for university
  475. Rapid and quantitative analysis of metabolites in fermentor broths using pyrolysis mass spectrometry with supervised learning: application to the screening of Penicillium chrysogenum fermentations for the overproduction of penicillins
  476. Biochemical changes accompanying the long-term starvation of Micrococcus luteus cells in spent growth medium
  477. Pheromones, social behaviour and the functions of secondary metabolism in bacteria
  478. The low-frequency dielectric properties of biological cells
  479. Secretion of an antibacterial factor during resuscitation of dormant cells inMicrococcus luteus cultures held in an extended stationary phase
  480. Use of dielectric permittivity for the control of the biomass level during biotransformations of toxic substrates in continuous culture
  481. Metabolic Channeling in Organized Enzyme Systems: Experiments and Models
  482. On harmonic generation in nonlinear biological systems
  483. Solvent Selection for Whole Cell Biotransformations in Organic Media
  484. Rapid screening for metabolite overproduction in fermentor broths, using pyrolysis mass spectrometry with multivariate calibration and artificial neural networks
  485. The dogs that did not bark
  486. Rapid and quantitative analysis of recombinant protein expression using pyrolysis mass spectrometry and artificial neural networks: application to mammalian cytochrome b5 in Escherichia coli
  487. The rainbow and the worm: the physics of organisms
  488. Rapid and Quantitative Analysis of the Pyrolysis Mass Spectra of Complex Binary and Tertiary Mixtures Using Multivariate Calibration and Artificial Neural Networks
  489. Rapid identification using pyrolysis mass spectrometry and artificial neural networks ofPropionibacterium acnesisolated from dogs
  490. Estimation of dormant Micrococcus luteus cells by penicillin lysis and by resuscitation in cell-free spent culture medium at high dilution
  491. Dielectric properties of human blood and erythrocytes at radio frequencies (0.2?10 MHz); dependence on cell volume fraction and medium composition
  492. Quantitative analysis of the pyrolysis—mass spectra of complex mixtures using artificial neural networks: Application to amino acids in glycogen
  493. Rapid and quantitative analysis and bioprocesses using pyrolysis mass spectrometry and neural networks: application to indole production
  494. Introduction to the dielectric estimation of cellular biomass in real time, with special emphasis on measurements at high volume fractions
  495. On the role of enzyme kinetic parameters in determining the effectiveness with which channelling can decrease the size of a metabolite pool
  496. Dormancy in non-sporulating bacteria
  497. Dormancy in non-sporulating bacteria
  498. The use of 5-cyano-2,3-ditolyl tetrazolium chloride and flow cytometry for the visualisation of respiratory activity in individual cells of Micrococcus luteus
  499. Control Analysis of Metabolic Channeling
  500. On the Determination of the Size of Microbial Cells Using Flow Cytometry
  501. Flow Cytometric Analysis, Using Rhodamine 123, of Micrococcus luteus at Low Growth Rate in Chemostat Culture
  502. When Going Backwards Means Progress: On the Solution of Biochemical Inverse Problems Using Artificial Neural Networks
  503. Rapid assessment of the adulteration of virgin olive oils by other seed oils using pyrolysis mass spectrometry and artificial neural networks
  504. On the dielectric method of monitoring cellular viability
  505. Non-linear dielectric properties of Rhodobacter capsulatus
  506. Neural networks and olive oil
  507. On fitting dielectric spectra using artificial neural networks
  508. On fitting dielectric spectra using artificial neural networks
  509. On the dielectric properties of cell suspensions at high volume fractions
  510. On the dielectric properties of cell suspensions at high volume fractions
  511. New materials and technology for cell immobilization
  512. Rapid assessment of bacterial viability and vitality by rhodamine 123 and flow cytometry
  513. Scanning tunnelling microscopy in biology
  514. New materials and technology for cell immobilization
  515. Scanning tunnelling microscopy in biology
  516. Channelling can decrease pool size
  517. Rapid Determination, Using Dielectric Spectroscopy, of the Toxicity of Organic Solvents to Intact Cells
  518. Quantifying heterogeneity: flow cytometry of bacterial cultures
  519. Physiological studies on the solid-state quinoa tempe fermentation, using on-line measurements of fungal biomass production
  520. On the relationship between the nonlinear dielectric properties and respiratory activity of the obligately aerobic bacterium Micrococcus luteus
  521. On the relationship between the nonlinear dielectric properties and respiratory activity of the obligately aerobic bacterium Micrococcus luteus
  522. Confirmation by using mutant strains that the membrane-bound H + -ATPase is the major source of non-linear dielectricity in Saccharomyces cerevisiae
  523. Confirmation by using mutant strains that the membrane-bound H+-ATPase is the major source of non-linear dielectricity in Saccharomyces cerevisiae
  524. The dielectric permittivity at radio frequencies and the bruggeman probe: novel techniques for the on-line determination of biomass concentrations in plant cell cultures
  525. On the physiological significance of metabolite channelling: If, how, and where, but not why
  526. Quantitative approaches to the analysis of the control and regulation of microbial metabolism
  527. New materials and technology for cell immobilization
  528. Dual-frequency excitation: A novel method for probing the nonlinear dielectric properties of biological systems, and its application to suspensions of S. cerevisiae
  529. Dual-frequency excitation: a novel method for probing the nonlinear dielectric properties of biological systems, and its application to suspensions of S. cerevisiae
  530. To what extent is the magnitude of the Cole-Cole α of the β-dielectric dispersion of cell suspensions explicable in terms of the cell size distribution?
  531. To what extent is the magnitude of the Cole—Cole α of the β-dielectric dispersion of cell suspensions explicable in terms of the cell size distribution?
  532. Lacuna seeker
  533. Real-time monitoring of the accretion of Rhizopus oligosporus biomass during the solid-substrate tempe fermentation
  534. Stimulation by potassium ions of the growth of Rhizopus oligosporus during liquid-and solid-substrate fermentations
  535. Non-Faradaic electrochemical sensors: principles and practice
  536. Solutions, but no answers
  537. Quantifying heterogeneity: flow cytometry of bacterial cultures
  538. On the nonlinear dielectric properties of biological systems
  539. On the nonlinear dielectric properties of biological systems
  540. Dielectric spectroscopy as a tool for the measurement of the formation of biofilms and of their removal by electrolytic cleaning pulses and biocides
  541. Real-time monitoring of cellular biomass: Methods and applications
  542. Evidence from its temperature dependence that the ?-dielectric dispersion of cell suspensions is not due solely to the charging of a static membrane capacitance
  543. Hydrodynamic deposition: A novel method of cell immobilization
  544. Substitution and spreadsheet methods for analysing dielectric spectra of biological systems
  545. The Dielectric Properties of Cells and Tissues: What can They Tell Us about the Mechanisms of Field/Cell Interactions?
  546. The control and measurement of ‘CO2’ during fermentations
  547. The inhibition by CO2of the growth and metabolism of micro-organisms
  548. Electromicrobial transformations using the pyruvate synthase system of Clostridium sporogenes
  549. Electromicrobial transformations using the pyruvate synthase system of Clostridium sporogenes
  550. Immobilisation ofCandida cylindracea lipase on a new range of ceramic supports
  551. Window boxes?
  552. Biosensors.
  553. Dielectric Spectroscopy: a Rapid Method for the Determination of Solvent Biocompatibility During Biotransformations
  554. Electrosynthesis and electroanalysis using Clostridium sporogenes
  555. On the audio- and radio-frequency dielectric behaviour of anchorage-independent, mouse L929-derived LS fibroblasts
  556. Electrosynthesis and electroanalysis using Clostridium sporogenes
  557. On the audio- and radio-frequency dielectric behaviour of anchorage-independent, mouse L929-derived LS fibroblasts
  558. Thermodynamics and control of biological free-energy transduction
  559. Mechanisms for the interaction between nonstationary electric fields and biological systems II. Nonlinear dielectric theory and free-energy transduction
  560. Mechanisms for the interaction between nonstationary electric fields and biological systems I. Linear dielectric theory and its limitations
  561. The dynamics of electrostatic interactions between membrane proteins
  562. Growth energetics ofClostridium sporogenesNCIB 8053: modulation by CO2
  563. Energetics of Microbial Growth Edwin H. Battley
  564. Effects ofpCO2on the growth and metabolism ofClostridium sporogenesNCIB 8053 in defined media
  565. The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology
  566. Matrix method for determining steps most rate-limiting to metabolic fluxes in biotechnological processes
  567. Dielectric permittivity of microbial suspensions at radio frequencies: a novel method for the real-time estimation of microbial biomass
  568. The growth and nutrition ofClostridium sporogenesNCIB 8053 in defined media
  569. The physiology ofClostridium sporogenesNCIB 8053 growing in defined media
  570. Solvent production byClostridium pasteurianum in media of high sugar content
  571. Metabolic control theory: its role in microbiology and biotechnology
  572. Metabolic control theory: its role in microbiology and biotechnology
  573. Proline reduction by Clostridium sporogenes is coupled to vectorial proton ejection
  574. Proline reduction by Clostridium sporogenes is coupled to vectorial proton ejection
  575. Dielectric spectroscopy of energy coupling membranes: Chloroplast thylakoids
  576. Towards a rational approach to the optimization of flux in microbial biotransformations
  577. Dielectric spectroscopy of protein translational diffusion in prokaryotic membranes and membrane vesicles
  578. [40] Localized protonic coupling: Overview and critical evaluation of techniques
  579. Organization and Control of Energy Metabolism in Anaerobic Microorganisms
  580. A Nomograph for Calculating the Optimal Frequency for Dielectrophoresis and the Characteristic Frequency of the β-Dispersion of Cell Membrane Vesicles
  581. Conductimetric assessment of the biomass content in suspensions of immobilised (gel-entrapped) microorganisms
  582. On the dielectrically observable consequences of the diffusional motions of lipids and proteins in membranes
  583. On the dielectrically observable consequences of the diffusional motions of lipids and proteins in membranes
  584. Tinopal AN as a selective agent for the differentiation of phytopathogenic and saprophyticPseudomonasspecies
  585. Catalytic Facilitation and Membrane Bioenergetics
  586. Dielectric Spectroscopy and Membrane Organisation
  587. The estimation of microbial biomass
  588. A minimal hypothesis for membrane-linked free-energy transduction
  589. Constraints on the lateral diffusion of membrane proteins in prokaryotes
  590. On the effects of thiocyanate and venturicidin on respiration-driven proton translocation in Paracoccus denitrificans
  591. Diffusion of protein complexes in prokaryotic membranes: fast, free, random or directed?
  592. Mosaic protonic coupling hypothesis for free energy transduction
  593. Is the Transmembrane Electrochemical Potential a Competent Intermediate in Membrane Associated ATP Synthesis?
  594. Dielectric properties of bacterial chromatophores
  595. The radio-frequency dielectric properties of yeast cells measured with a rapid, automated, frequency-domain dielectric spectrometer
  596. Coupling factor B and the bovine mitochondrial H+-ATP synthase
  597. On the functional unit of energy coupling in photophosphorylation by bacterial chromatophores
  598. Non-linear systems: Coherent excitation in biology
  599. Coherent Properties of the Membranous Systems of Electron Transport Phosphorylation
  600. Dielectric properties of bacterial chromatophores
  601. The radio-frequency dielectric properties of yeast cells measured with a rapid, automated, frequency-domain dielectric spectrometer
  602. Enzymes as energy ‘funnels’?
  603. Localized energy coupling during photophosphorylation by chromatophores ofRhodopseudomonas capsulata N22
  604. On the Mode of Action of the Bacteriocin Butyricin 7423. Effects on Membrane Potential and Potassium-Ion Accumulation in Clostridium pasteurianum
  605. A novel inhibitor of NADH dehydrogenase in Paracoccus denitrificans
  606. Butyricin 7423 and the membrane H+-ATPase of Clostridium pasteurianum
  607. General discussion
  608. Proton-coupled energy transduction by biological membranes. Principles, pathways and praxis
  609. A rose by any other name
  610. Bacteria that are resistant to uncouplers—what can they tell us?
  611. Quantitative Problems in Biochemistry (Sixth Edition)
  612. A benzoxazole inhibitor of NADH dehydrogenase in Paracoccus denitrificans
  613. A benzoxazole inhibitor of NADH dehydrogenase in Paracoccus denitrificans
  614. Polarographic investigation of some cytokinins
  615. On proton-coupled information transfer along the surface of biological membranes and the mode of action of certain colicins
  616. Polarographic investigation of some cytokinins
  617. On proton-coupled information transfer along the surface of biological membranes and the mode of action of certain colicins
  618. On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridiumpasteurianum
  619. The Electron Transport System and Hydrogenase of Paracoccus denitrificans
  620. Medical and biological applications of electrochemical devices
  621. Edited by G. Milazzo J. Wiley; Brisbane, Chichester, New York, Toronto
  622. Edited by P. L. Dutton, J. S. Leigh and A. Scarpa Academic Press; London, New York
  623. Formulation and some biological uses of a buffer mixture whose buffering capacity is relatively independent of pH in the range pH 4–9
  624. An adenine nucleotide translocase in the procaryote Methanobacterium thermoautotrophicum
  625. Oxidation-reduction properties of coenzyme M (2-mercaptoethane sulphonate) at the mercury electrode
  626. Physical Aspects of Protein Interactions
  627. Physiochemical Aspects of Protein Denaturation
  628. Biochemical Thermodynamics
  629. On the functional proton current pathway of electron transport phosphorylation
  630. Measurement by a flow dialysis technique of the steady-state proton-motive force in chromatophores from Rhodospirillum rubrum. Comparison with phosphorylation potential
  631. Resolution of Paracoccus denitrificans membrane vesicles of differing configuration using affinity chromatography
  632. Continuous monitoring of the electrical potential across energy-transducing membranes using ion-selective electrodes Application to submitochondrial particles and chromatophores
  633. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses
  634. Douglas Kell Comments on ‘Methodology’ During the Workshop
  635. Taverna/myGrid: Aligning a Workflow System with the Life Sciences Community
  636. Molecular Structure Elucidation Using Ant Colony Optimization: A Preliminary Study
  637. Nonlinear Dielectric Spectroscopy of Biological Systems: Principles ans Applications